Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry Dapeng SunRaynald -Zhongrong Miao OriginalPaper 27 October 2022 Pages: 1 - 8
Platelet storage: Progress so far Vani RajashekaraiahMagdaline Christina Rajanand ReviewPaper 31 October 2022 Pages: 9 - 17
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis Xiaojie ZhengFangbo GaoXingshun Qi OriginalPaper 19 November 2022 Pages: 18 - 31
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients Julie WangHui Yin LimPrahlad Ho OriginalPaper Open access 31 July 2022 Pages: 32 - 41
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention Ioannis LianosCharalampos VarlamosDimitrios Alexopoulos OriginalPaper Open access 12 November 2022 Pages: 42 - 50
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism Giuseppe FiorentinoGiuditta BenincasaClaudio Napoli OriginalPaper Open access 13 November 2022 Pages: 51 - 59
l-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates Saeede BagheriShahram SamieeMohammad Reza Deyhim OriginalPaper 15 November 2022 Pages: 60 - 66
Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest XinLiang GuanLei LiHongJia Zhang OriginalPaper 28 September 2022 Pages: 67 - 73
Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study Brian D. AdkinsHila ShaimSean G. Yates OriginalPaper 14 June 2022 Pages: 74 - 82
Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis Tiffany T. S. YeQi Zhuang SiahChing-Hui Sia ReviewPaper 03 October 2022 Pages: 83 - 91
Net clinical benefit of DOACs vs. usual anticoagulation treatment in venous thromboembolism and active cancer: systematic review and meta-analysis Helena MichalopoulouDimitris PolyzosEmmanouil Vavouranakis ReviewPaper 28 October 2022 Pages: 92 - 101
Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosis Javad AhmadiEhteramolsadat HosseiniMehran Ghasemzadeh OriginalPaper 09 November 2022 Pages: 102 - 115
Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions Fan ZhangXudong CaoXiaolin Chen OriginalPaper 17 November 2022 Pages: 116 - 125
A multicentre observational study of the prevalence, management, and outcomes of subsegmental pulmonary embolism Michael N ArmitageAishah Z MughalMichael Newnham OriginalPaper Open access 07 November 2022 Pages: 126 - 133
Time from blood draw to multiple electrode aggregometry and association with platelet reactivity David HesselbarthDiona GjermeniChristoph B. Olivier OriginalPaper Open access 08 November 2022 Pages: 134 - 140
Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin Delaney FeldeisenConstantina Alexandris-SouphisEva Kline-Rogers OriginalPaper 03 November 2022 Pages: 141 - 148
Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage Camille TroyerWesley NguyenDexter Wimer OriginalPaper Open access 10 November 2022 Pages: 149 - 155
Temporal trend in venous thromboembolism hospitalization rates in Brazilian older adults, 2010–2020 Milara BarpViviane Santos Mendes CarneiroValéria Pagotto OriginalPaper 06 November 2022 Pages: 156 - 165
Impact of clinical profile at admission on the outcomes in patients hospitalized for acute pulmonary embolism: data from the IPER Registry Marco ZuinClaudio BilatoLoris Roncon OriginalPaper 09 November 2022 Pages: 166 - 174
Use of SAMe-TT2R2 in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation Kunkun WangYun LuRichard W Asinger OriginalPaper 09 November 2022 Pages: 175 - 180
TAVR: nemesis of NOACs? Amin PolzinCarolin HeltenTobias Zeus Report Open access 01 November 2022 Pages: 181 - 184
Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants Anisa AmirtabarSara R. VazquezDaniel M. Witt BriefCommunication 20 April 2022 Pages: 185 - 188
Association between thromboembolic events and COVID-19 infection within 30 days: a case–control study among a large sample of adult hospitalized patients in the United States, March 2020–June 2021 Ya-Lin A. HuangHussain YusufAaron M. Harris BriefCommunication 14 December 2022 Pages: 189 - 194
Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison Samantha PascaPierGiorgio Cojuttifor the Italian rFXIII Study Group Correction 01 December 2022 Pages: 195 - 195